LymphedemaV1, Main, Exploration, bibRecordById, PMC:3205627

Costs of Integrated Mass Drug Administration for Neglected Tropical Diseases in Haiti

Identifieur interne : 004F73 ( Main/Exploration ); précédent : 004F72; suivant : 004F74

Costs of Integrated Mass Drug Administration for Neglected Tropical Diseases in Haiti

Auteurs : Ann S. Goldman ; Molly A. Brady ; Abdel Direny ; Luccene Desir ; Roland Oscard ; Jean-Francois Vely ; Mary Linehan ; Margaret Baker

Source :

The American Journal of Tropical Medicine and Hygiene [ 0002-9637 ] ; 2011.

RBID : PMC:3205627

Descripteurs français

KwdFr :
- Albendazole (administration et posologie), Albendazole (usage thérapeutique), Albendazole (économie), Antihelminthiques (administration et posologie), Antihelminthiques (usage thérapeutique), Antihelminthiques (économie), Coûts et analyse des coûts, Diéthylcarbamazine (administration et posologie), Diéthylcarbamazine (usage thérapeutique), Diéthylcarbamazine (économie), Filariose lymphatique (traitement médicamenteux), Filariose lymphatique (économie), Filariose lymphatique (épidémiologie), Haïti (épidémiologie), Helminthiase (traitement médicamenteux), Helminthiase (économie), Helminthiase (épidémiologie), Humains, Maladies négligées (traitement médicamenteux), Maladies négligées (économie), Maladies négligées (épidémiologie), Prévalence, Traitement médicamenteux (), Traitement médicamenteux (économie).
MESH :
- administration et posologie : Albendazole, Antihelminthiques, Diéthylcarbamazine.
- traitement médicamenteux : Filariose lymphatique, Helminthiase, Maladies négligées.
- usage thérapeutique : Albendazole, Antihelminthiques, Diéthylcarbamazine.
- économie : Albendazole, Antihelminthiques, Diéthylcarbamazine, Filariose lymphatique, Helminthiase, Maladies négligées, Traitement médicamenteux.
- épidémiologie : Filariose lymphatique, Haïti, Helminthiase, Maladies négligées.
- Coûts et analyse des coûts, Humains, Prévalence, Traitement médicamenteux.
Wicri :
- geographic : Haïti.

English descriptors

KwdEn :
- Albendazole (administration & dosage), Albendazole (economics), Albendazole (therapeutic use), Anthelmintics (administration & dosage), Anthelmintics (economics), Anthelmintics (therapeutic use), Costs and Cost Analysis, Diethylcarbamazine (administration & dosage), Diethylcarbamazine (economics), Diethylcarbamazine (therapeutic use), Drug Therapy (economics), Drug Therapy (methods), Elephantiasis, Filarial (drug therapy), Elephantiasis, Filarial (economics), Elephantiasis, Filarial (epidemiology), Haiti (epidemiology), Helminthiasis (drug therapy), Helminthiasis (economics), Helminthiasis (epidemiology), Humans, Neglected Diseases (drug therapy), Neglected Diseases (economics), Neglected Diseases (epidemiology), Prevalence.
MESH :
- chemical , administration & dosage : Albendazole, Anthelmintics, Diethylcarbamazine.
- chemical , economics : Albendazole, Anthelmintics, Diethylcarbamazine.
- chemical , therapeutic use : Albendazole, Anthelmintics, Diethylcarbamazine.
- geographic , epidemiology : Haiti.
- drug therapy : Elephantiasis, Filarial, Helminthiasis, Neglected Diseases.
- economics : Drug Therapy, Elephantiasis, Filarial, Helminthiasis, Neglected Diseases.
- epidemiology : Elephantiasis, Filarial, Helminthiasis, Neglected Diseases.
- methods : Drug Therapy.
- Costs and Cost Analysis, Humans, Prevalence.

Abstract

We conducted a cost analysis of Haiti's Ministry of Public Health and Population neglected tropical disease program, Projet des Maladies Tropicales Negligées and collected data for 9 of 55 communes participating in the May 2008–April 2009 mass drug administration (MDA). The Projet des Maladies Tropicales Negligées Program partnered with IMA World Health and Hôpital Ste. Croix to implement MDA for treatment of lymphatic filariasis and soil-transmitted helminthiasis by using once a year treatment with albendazole and diethylcarbamazine in a population of approximately 8 million persons. Methods included analyzing partner financial records and conducting retrospective surveys of personnel. In the nine communes, 633,261 persons were treated at a cost of U.S. $0.64 per person, which included the cost of donated drugs, and at a cost of U.S. $0.42 per person treated, when excluding donated drug costs. The MDA for lymphatic filariasis in Haiti began in 2000, with the treatment of 105,750 persons at a cost per person of U.S. $2.23. The decrease in cost per person treated is the result of cumulative implementation experience and economies of scale.

Url:

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3205627

DOI: 10.4269/ajtmh.2011.10-0635
PubMed: 22049035
PubMed Central: 3205627

Affiliations:

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Costs of Integrated Mass Drug Administration for Neglected Tropical Diseases in Haiti</title>
<author><name sortKey="Goldman, Ann S" sort="Goldman, Ann S" uniqKey="Goldman A" first="Ann S." last="Goldman">Ann S. Goldman</name>
</author>
<author><name sortKey="Brady, Molly A" sort="Brady, Molly A" uniqKey="Brady M" first="Molly A." last="Brady">Molly A. Brady</name>
</author>
<author><name sortKey="Direny, Abdel" sort="Direny, Abdel" uniqKey="Direny A" first="Abdel" last="Direny">Abdel Direny</name>
</author>
<author><name sortKey="Desir, Luccene" sort="Desir, Luccene" uniqKey="Desir L" first="Luccene" last="Desir">Luccene Desir</name>
</author>
<author><name sortKey="Oscard, Roland" sort="Oscard, Roland" uniqKey="Oscard R" first="Roland" last="Oscard">Roland Oscard</name>
</author>
<author><name sortKey="Vely, Jean Francois" sort="Vely, Jean Francois" uniqKey="Vely J" first="Jean-Francois" last="Vely">Jean-Francois Vely</name>
</author>
<author><name sortKey="Linehan, Mary" sort="Linehan, Mary" uniqKey="Linehan M" first="Mary" last="Linehan">Mary Linehan</name>
</author>
<author><name sortKey="Baker, Margaret" sort="Baker, Margaret" uniqKey="Baker M" first="Margaret" last="Baker">Margaret Baker</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">22049035</idno>
<idno type="pmc">3205627</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3205627</idno>
<idno type="RBID">PMC:3205627</idno>
<idno type="doi">10.4269/ajtmh.2011.10-0635</idno>
<date when="2011">2011</date>
<idno type="wicri:Area/Pmc/Corpus">002C14</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">002C14</idno>
<idno type="wicri:Area/Pmc/Curation">002C13</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">002C13</idno>
<idno type="wicri:Area/Pmc/Checkpoint">003022</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">003022</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="wicri:Area/PubMed/Corpus">002406</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002406</idno>
<idno type="wicri:Area/PubMed/Curation">002406</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002406</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002406</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002406</idno>
<idno type="wicri:Area/Ncbi/Merge">004790</idno>
<idno type="wicri:Area/Ncbi/Curation">004790</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">004790</idno>
<idno type="wicri:doubleKey">0002-9637:2011:Goldman A:costs:of:integrated</idno>
<idno type="wicri:Area/Main/Merge">005009</idno>
<idno type="wicri:Area/Main/Curation">004F73</idno>
<idno type="wicri:Area/Main/Exploration">004F73</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Costs of Integrated Mass Drug Administration for Neglected Tropical Diseases in Haiti</title>
<author><name sortKey="Goldman, Ann S" sort="Goldman, Ann S" uniqKey="Goldman A" first="Ann S." last="Goldman">Ann S. Goldman</name>
</author>
<author><name sortKey="Brady, Molly A" sort="Brady, Molly A" uniqKey="Brady M" first="Molly A." last="Brady">Molly A. Brady</name>
</author>
<author><name sortKey="Direny, Abdel" sort="Direny, Abdel" uniqKey="Direny A" first="Abdel" last="Direny">Abdel Direny</name>
</author>
<author><name sortKey="Desir, Luccene" sort="Desir, Luccene" uniqKey="Desir L" first="Luccene" last="Desir">Luccene Desir</name>
</author>
<author><name sortKey="Oscard, Roland" sort="Oscard, Roland" uniqKey="Oscard R" first="Roland" last="Oscard">Roland Oscard</name>
</author>
<author><name sortKey="Vely, Jean Francois" sort="Vely, Jean Francois" uniqKey="Vely J" first="Jean-Francois" last="Vely">Jean-Francois Vely</name>
</author>
<author><name sortKey="Linehan, Mary" sort="Linehan, Mary" uniqKey="Linehan M" first="Mary" last="Linehan">Mary Linehan</name>
</author>
<author><name sortKey="Baker, Margaret" sort="Baker, Margaret" uniqKey="Baker M" first="Margaret" last="Baker">Margaret Baker</name>
</author>
</analytic>
<series><title level="j">The American Journal of Tropical Medicine and Hygiene</title>
<idno type="ISSN">0002-9637</idno>
<idno type="eISSN">1476-1645</idno>
<imprint><date when="2011">2011</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Albendazole (administration & dosage)</term>
<term>Albendazole (economics)</term>
<term>Albendazole (therapeutic use)</term>
<term>Anthelmintics (administration & dosage)</term>
<term>Anthelmintics (economics)</term>
<term>Anthelmintics (therapeutic use)</term>
<term>Costs and Cost Analysis</term>
<term>Diethylcarbamazine (administration & dosage)</term>
<term>Diethylcarbamazine (economics)</term>
<term>Diethylcarbamazine (therapeutic use)</term>
<term>Drug Therapy (economics)</term>
<term>Drug Therapy (methods)</term>
<term>Elephantiasis, Filarial (drug therapy)</term>
<term>Elephantiasis, Filarial (economics)</term>
<term>Elephantiasis, Filarial (epidemiology)</term>
<term>Haiti (epidemiology)</term>
<term>Helminthiasis (drug therapy)</term>
<term>Helminthiasis (economics)</term>
<term>Helminthiasis (epidemiology)</term>
<term>Humans</term>
<term>Neglected Diseases (drug therapy)</term>
<term>Neglected Diseases (economics)</term>
<term>Neglected Diseases (epidemiology)</term>
<term>Prevalence</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Albendazole (administration et posologie)</term>
<term>Albendazole (usage thérapeutique)</term>
<term>Albendazole (économie)</term>
<term>Antihelminthiques (administration et posologie)</term>
<term>Antihelminthiques (usage thérapeutique)</term>
<term>Antihelminthiques (économie)</term>
<term>Coûts et analyse des coûts</term>
<term>Diéthylcarbamazine (administration et posologie)</term>
<term>Diéthylcarbamazine (usage thérapeutique)</term>
<term>Diéthylcarbamazine (économie)</term>
<term>Filariose lymphatique (traitement médicamenteux)</term>
<term>Filariose lymphatique (économie)</term>
<term>Filariose lymphatique (épidémiologie)</term>
<term>Haïti (épidémiologie)</term>
<term>Helminthiase (traitement médicamenteux)</term>
<term>Helminthiase (économie)</term>
<term>Helminthiase (épidémiologie)</term>
<term>Humains</term>
<term>Maladies négligées (traitement médicamenteux)</term>
<term>Maladies négligées (économie)</term>
<term>Maladies négligées (épidémiologie)</term>
<term>Prévalence</term>
<term>Traitement médicamenteux ()</term>
<term>Traitement médicamenteux (économie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Albendazole</term>
<term>Anthelmintics</term>
<term>Diethylcarbamazine</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="economics" xml:lang="en"><term>Albendazole</term>
<term>Anthelmintics</term>
<term>Diethylcarbamazine</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Albendazole</term>
<term>Anthelmintics</term>
<term>Diethylcarbamazine</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Haiti</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Albendazole</term>
<term>Antihelminthiques</term>
<term>Diéthylcarbamazine</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Elephantiasis, Filarial</term>
<term>Helminthiasis</term>
<term>Neglected Diseases</term>
</keywords>
<keywords scheme="MESH" qualifier="economics" xml:lang="en"><term>Drug Therapy</term>
<term>Elephantiasis, Filarial</term>
<term>Helminthiasis</term>
<term>Neglected Diseases</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Elephantiasis, Filarial</term>
<term>Helminthiasis</term>
<term>Neglected Diseases</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Drug Therapy</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Filariose lymphatique</term>
<term>Helminthiase</term>
<term>Maladies négligées</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Albendazole</term>
<term>Antihelminthiques</term>
<term>Diéthylcarbamazine</term>
</keywords>
<keywords scheme="MESH" qualifier="économie" xml:lang="fr"><term>Albendazole</term>
<term>Antihelminthiques</term>
<term>Diéthylcarbamazine</term>
<term>Filariose lymphatique</term>
<term>Helminthiase</term>
<term>Maladies négligées</term>
<term>Traitement médicamenteux</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Filariose lymphatique</term>
<term>Haïti</term>
<term>Helminthiase</term>
<term>Maladies négligées</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Costs and Cost Analysis</term>
<term>Humans</term>
<term>Prevalence</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Coûts et analyse des coûts</term>
<term>Humains</term>
<term>Prévalence</term>
<term>Traitement médicamenteux</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Haïti</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p>We conducted a cost analysis of Haiti's Ministry of Public Health and Population neglected tropical disease program, Projet des Maladies Tropicales Negligées and collected data for 9 of 55 communes participating in the May 2008–April 2009 mass drug administration (MDA). The Projet des Maladies Tropicales Negligées Program partnered with IMA World Health and Hôpital Ste. Croix to implement MDA for treatment of lymphatic filariasis and soil-transmitted helminthiasis by using once a year treatment with albendazole and diethylcarbamazine in a population of approximately 8 million persons. Methods included analyzing partner financial records and conducting retrospective surveys of personnel. In the nine communes, 633,261 persons were treated at a cost of U.S. $0.64 per person, which included the cost of donated drugs, and at a cost of U.S. $0.42 per person treated, when excluding donated drug costs. The MDA for lymphatic filariasis in Haiti began in 2000, with the treatment of 105,750 persons at a cost per person of U.S. $2.23. The decrease in cost per person treated is the result of cumulative implementation experience and economies of scale.</p>
</div>
</front>
</TEI>
<affiliations><list></list>
<tree><noCountry><name sortKey="Baker, Margaret" sort="Baker, Margaret" uniqKey="Baker M" first="Margaret" last="Baker">Margaret Baker</name>
<name sortKey="Brady, Molly A" sort="Brady, Molly A" uniqKey="Brady M" first="Molly A." last="Brady">Molly A. Brady</name>
<name sortKey="Desir, Luccene" sort="Desir, Luccene" uniqKey="Desir L" first="Luccene" last="Desir">Luccene Desir</name>
<name sortKey="Direny, Abdel" sort="Direny, Abdel" uniqKey="Direny A" first="Abdel" last="Direny">Abdel Direny</name>
<name sortKey="Goldman, Ann S" sort="Goldman, Ann S" uniqKey="Goldman A" first="Ann S." last="Goldman">Ann S. Goldman</name>
<name sortKey="Linehan, Mary" sort="Linehan, Mary" uniqKey="Linehan M" first="Mary" last="Linehan">Mary Linehan</name>
<name sortKey="Oscard, Roland" sort="Oscard, Roland" uniqKey="Oscard R" first="Roland" last="Oscard">Roland Oscard</name>
<name sortKey="Vely, Jean Francois" sort="Vely, Jean Francois" uniqKey="Vely J" first="Jean-Francois" last="Vely">Jean-Francois Vely</name>
</noCountry>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004F73 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004F73 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     PMC:3205627
   |texte=   Costs of Integrated Mass Drug Administration for Neglected Tropical Diseases in Haiti
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:22049035" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024

Serveur d'exploration sur le lymphœdème

Costs of Integrated Mass Drug Administration for Neglected Tropical Diseases in Haiti

Costs of Integrated Mass Drug Administration for Neglected Tropical Diseases in Haiti

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki

	Serveur d'exploration sur le lymphœdème
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.